blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2708145

EP2708145 - Nutritional compositions for use in methods for modulating corticosterone levels in psychologically stressed individuals [Right-click to bookmark this link]
Former [2014/12]Methods for modulating corticosterone levels in psychologically stressed individuals
[2015/44]
StatusOpposition rejected
Status updated on  05.04.2019
Database last updated on 24.08.2024
FormerThe patent has been granted
Status updated on  19.12.2018
Most recent event   Tooltip05.04.2019Opposition rejectedpublished on 08.05.2019  [2019/19]
Applicant(s)For all designated states
ABBOTT LABORATORIES
100 Abbott Park Road
Abbott Park, IL 60064-3500 / US
[2016/18]
Former [2014/36]For all designated states
ABBOTT LABORATORIES
100 Abbott Park Road
Abbott Park, IL 60064-3500 / US
Former [2014/12]For all designated states
Abbott Laboratories, Inc.
100, Abbott Park Road
Abbott Park, IL 60064 / US
Inventor(s)01 / Vazquez Hernandez, Enrique
ABBOTT LABORATORIES
Camino de Gojar, 42.
Urb. Los Nenufares, 52
18151 Ogijares (Granada) / ES
02 / Rueda Cabrera, Ricardo
ABBOTT LABORATORIES
Brazal, 2
18008 Granada / ES
03 / Buck, Rachael
ABBOTT LABORATORIES
3710 Peak Ridge Drive
Gahanna, OH 43230 / US
04 / Ramirez Gonzalez, Maria
ABBOTT LABORATORIES
Ramón y Cajal, 54.
Portal 2- 4A
18003 Granada / ES
 [2014/12]
Representative(s)Boult Wade Tennant LLP
Salisbury Square House
8 Salisbury Square
London EC4Y 8AP / GB
[N/P]
Former [2016/18]Boult Wade Tennant
Verulam Gardens
70 Gray's Inn Road
London WC1X 8BT / GB
Former [2014/12]Ungria López, Javier
Avda. Ramón y Cajal, 78
28043 Madrid / ES
Application number, filing date12382354.414.09.2012
[2014/12]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2708145
Date:19.03.2014
Language:EN
[2014/12]
Type: A8 Corrected patent application 
No.:EP2708145
Date:03.09.2014
[2014/36]
Type: B1 Patent specification 
No.:EP2708145
Date:04.05.2016
Language:EN
[2016/18]
Search report(s)(Supplementary) European search report - dispatched on:EP28.01.2013
ClassificationIPC:A23L33/00, A23L33/20, A61K31/702, A61K35/20, // A61P25/00
[2016/17]
CPC:
A61K31/702 (EP,CN,US); A61K9/0095 (EP,CN,US); A23L33/21 (EP,US);
A23L33/40 (EP,US); A61P25/00 (EP); A61P5/46 (EP);
A23V2002/00 (CN,US) (-)
C-Set:
A23V2002/00, A23V2250/612 (CN)
Former IPC [2014/12]A23L1/29, A23L1/308, A61K31/702, A61K35/20, // A61P25/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/18]
Former [2014/12]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:Nahrungsmitteln zur Verwendung zur Modulation von Corticosteronspiegeln bei psychisch belasteten Menschen[2015/44]
English:Nutritional compositions for use in methods for modulating corticosterone levels in psychologically stressed individuals[2015/44]
French:Compositions nutritionnelles pour utilisation dans des méthodes pour moduler les niveaux de corticostérone chez des individus psychologiquement stressés[2015/44]
Former [2014/12]Verfahren zur Modulation von Corticosteronspiegeln bei psychisch belasteten Menschen
Former [2014/12]Methods for modulating corticosterone levels in psychologically stressed individuals
Former [2014/12]Procédés pour moduler les niveaux de corticostérone chez des individus psychologiquement stressés
Examination procedure22.07.2014Amendment by applicant (claims and/or description)
22.07.2014Examination requested  [2014/35]
23.09.2014Despatch of a communication from the examining division (Time limit: M04)
20.01.2015Reply to a communication from the examining division
21.04.2015Despatch of a communication from the examining division (Time limit: M03)
21.07.2015Reply to a communication from the examining division
23.10.2015Communication of intention to grant the patent
01.03.2016Fee for grant paid
01.03.2016Fee for publishing/printing paid
01.03.2016Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  23.09.2014
Opposition(s)Opponent(s)01  03.02.2017  09.02.2017  ADMISSIBLE
N.V. Nutricia
Eerste Stationsstraat 186
2712 HM Zoetermeer / NL
Opponent's representative
Nederlandsch Octrooibureau
P.O. Box 29720
2502 LS The Hague / NL
 [2017/11]
16.03.2017Invitation to proprietor to file observations on the notice of opposition
26.07.2017Reply of patent proprietor to notice(s) of opposition
04.12.2018Legal effect of rejection of opposition [2019/19]
04.12.2018Date of oral proceedings
20.12.2018Despatch of minutes of oral proceedings
20.12.2018Date of despatch of rejection of opposition
Fees paidRenewal fee
08.09.2014Renewal fee patent year 03
08.09.2015Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU14.09.2012
AL04.05.2016
AT04.05.2016
BE04.05.2016
BG04.05.2016
CY04.05.2016
CZ04.05.2016
EE04.05.2016
FI04.05.2016
HR04.05.2016
IS04.05.2016
IT04.05.2016
LT04.05.2016
LV04.05.2016
MC04.05.2016
MK04.05.2016
PL04.05.2016
RO04.05.2016
RS04.05.2016
SE04.05.2016
SI04.05.2016
SK04.05.2016
SM04.05.2016
NO04.08.2016
GR05.08.2016
PT05.09.2016
LU14.09.2016
FR30.09.2016
MT30.09.2016
[2018/46]
Former [2018/38]HU14.09.2012
AT04.05.2016
BE04.05.2016
BG04.05.2016
CY04.05.2016
CZ04.05.2016
EE04.05.2016
FI04.05.2016
HR04.05.2016
IS04.05.2016
IT04.05.2016
LT04.05.2016
LV04.05.2016
MC04.05.2016
MK04.05.2016
PL04.05.2016
RO04.05.2016
RS04.05.2016
SE04.05.2016
SI04.05.2016
SK04.05.2016
SM04.05.2016
NO04.08.2016
GR05.08.2016
PT05.09.2016
LU14.09.2016
FR30.09.2016
MT30.09.2016
Former [2018/31]HU14.09.2012
AT04.05.2016
BE04.05.2016
CY04.05.2016
CZ04.05.2016
EE04.05.2016
FI04.05.2016
HR04.05.2016
IS04.05.2016
IT04.05.2016
LT04.05.2016
LV04.05.2016
MC04.05.2016
MK04.05.2016
PL04.05.2016
RO04.05.2016
RS04.05.2016
SE04.05.2016
SI04.05.2016
SK04.05.2016
SM04.05.2016
NO04.08.2016
GR05.08.2016
PT05.09.2016
LU14.09.2016
FR30.09.2016
MT30.09.2016
Former [2018/28]HU14.09.2012
AT04.05.2016
BE04.05.2016
CY04.05.2016
CZ04.05.2016
EE04.05.2016
FI04.05.2016
HR04.05.2016
IT04.05.2016
LT04.05.2016
LV04.05.2016
MC04.05.2016
MK04.05.2016
PL04.05.2016
RO04.05.2016
RS04.05.2016
SE04.05.2016
SI04.05.2016
SK04.05.2016
SM04.05.2016
NO04.08.2016
GR05.08.2016
PT05.09.2016
LU14.09.2016
FR30.09.2016
Former [2017/42]AT04.05.2016
BE04.05.2016
CZ04.05.2016
EE04.05.2016
FI04.05.2016
HR04.05.2016
IT04.05.2016
LT04.05.2016
LV04.05.2016
MC04.05.2016
PL04.05.2016
RO04.05.2016
RS04.05.2016
SE04.05.2016
SI04.05.2016
SK04.05.2016
SM04.05.2016
NO04.08.2016
GR05.08.2016
PT05.09.2016
LU14.09.2016
FR30.09.2016
Former [2017/37]AT04.05.2016
BE04.05.2016
CZ04.05.2016
EE04.05.2016
FI04.05.2016
HR04.05.2016
IT04.05.2016
LT04.05.2016
LV04.05.2016
MC04.05.2016
PL04.05.2016
RO04.05.2016
RS04.05.2016
SE04.05.2016
SI04.05.2016
SK04.05.2016
SM04.05.2016
NO04.08.2016
GR05.08.2016
PT05.09.2016
FR30.09.2016
Former [2017/31]AT04.05.2016
BE04.05.2016
CZ04.05.2016
EE04.05.2016
FI04.05.2016
HR04.05.2016
IT04.05.2016
LT04.05.2016
LV04.05.2016
MC04.05.2016
PL04.05.2016
RO04.05.2016
RS04.05.2016
SE04.05.2016
SI04.05.2016
SK04.05.2016
SM04.05.2016
NO04.08.2016
GR05.08.2016
PT05.09.2016
Former [2017/11]AT04.05.2016
BE04.05.2016
CZ04.05.2016
EE04.05.2016
FI04.05.2016
HR04.05.2016
IT04.05.2016
LT04.05.2016
LV04.05.2016
PL04.05.2016
RO04.05.2016
RS04.05.2016
SE04.05.2016
SK04.05.2016
SM04.05.2016
NO04.08.2016
GR05.08.2016
PT05.09.2016
Former [2017/10]BE04.05.2016
CZ04.05.2016
EE04.05.2016
FI04.05.2016
HR04.05.2016
IT04.05.2016
LT04.05.2016
LV04.05.2016
PL04.05.2016
RO04.05.2016
RS04.05.2016
SE04.05.2016
SK04.05.2016
NO04.08.2016
GR05.08.2016
PT05.09.2016
Former [2017/09]CZ04.05.2016
EE04.05.2016
FI04.05.2016
HR04.05.2016
IT04.05.2016
LT04.05.2016
LV04.05.2016
RO04.05.2016
RS04.05.2016
SE04.05.2016
NO04.08.2016
GR05.08.2016
PT05.09.2016
Former [2017/04]FI04.05.2016
HR04.05.2016
IT04.05.2016
LT04.05.2016
LV04.05.2016
RS04.05.2016
SE04.05.2016
NO04.08.2016
GR05.08.2016
PT05.09.2016
Former [2016/52]FI04.05.2016
HR04.05.2016
LT04.05.2016
LV04.05.2016
RS04.05.2016
SE04.05.2016
NO04.08.2016
GR05.08.2016
PT05.09.2016
Former [2016/51]FI04.05.2016
HR04.05.2016
LT04.05.2016
LV04.05.2016
RS04.05.2016
NO04.08.2016
GR05.08.2016
PT05.09.2016
Former [2016/50]FI04.05.2016
HR04.05.2016
LT04.05.2016
LV04.05.2016
RS04.05.2016
NO04.08.2016
Former [2016/49]FI04.05.2016
LT04.05.2016
NO04.08.2016
Former [2016/46]LT04.05.2016
NO04.08.2016
Documents cited:Search[A]WO2011005681  (CHILDRENS HOSP MEDICAL CENTER [US], et al) [A] 1-15 * page 1, lines 23-26 * * page 2, lines 9-22 * * table 1 * * page 8, lines 6-26 *;
 [A]US2012172307  (DAVIS STEVEN R [US], et al) [A] 1-15 * paragraphs [0002] , [0013] - [0015] - [0032] , [0074] , [0140] - [0150] *;
 [A]US2012172327  (BUCK RACHAEL [US], et al) [A] 1-15 * paragraphs [0002] , [0003] , [0006] , [0007] , [0012] - [0015] - [0033] , [0047] , [0050] , [0075] * * paragraphs [0143] - [0151] *;
 [A]US2012172319  (CHOW JOMAY [US], et al) [A] 1-15 * paragraphs [0003] , [0005] , [0010] , [0013] , [0016] , [0143] - [0149] *;
 [A]  - KUNZ C ET AL, "OLIGOSACCHARIDES IN HUMAN MILK: STRUCTURAL, FUNCTIONAL, AND METABOLIC ASPECTS", ANNUAL REVIEW OF NUTRITION, ANNUAL REVIEWS INC., PALO ALTO, CA, US, (20000101), vol. 20, doi:10.1146/ANNUREV.NUTR.20.1.699, ISSN 0199-9885, pages 699 - 722, XP009020860 [A] 1-15 * abstract * * pages 706-707 * * page 710 * * table 2 *

DOI:   http://dx.doi.org/10.1146/annurev.nutr.20.1.699
 [A]  - Wang, B. et al, "Dietary sialic acid supplementation improves learning and memory in piglets", Am. J. Clin. Nutr., vol. 85, no. 2, (20070101), pages 561 - 569, URL: http://ajcn.nutrition.org/content/85/2/561.full.pdf#page=1&view=FitH, (20130117), XP055050164 [A] 1-15 * abstract * * pages 567-8 * * page 2; figure 2 *
by applicantUS6306908
 US6365218
 US2003118703
 US6589576
OppositionWO2011008087
 WO2012092155
 WO2012092160
 WO2012107865
    - "Corticosterone", Wikipedia, the free encyclopedia, (20161216), URL: https://en.wikipedia.org/wiki/Corticosterone, XP055352330
    - SUDO et al., "Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice", J. physiol., (20040000), vol. 558, no. 1, pages 263 - 275, XP055352332

DOI:   http://dx.doi.org/10.1113/jphysiol.2004.063388
    - GAREAU et al., "Probiotic treatment of rat pups normalises corticosterone release and ameliorates colonic dysfunction induced by maternal separation", Gut, (20070000), vol. 56, pages 1522 - 1528, XP055352335

DOI:   http://dx.doi.org/10.1136/gut.2006.117176
    - SCHWAB et al., "Lactic acid bacteria fermentation of human milk oligosaccharide components, human milk oligosaccharides and galactooligosaccharides", FEMS Micribiol. Lett., (20110200), vol. 315, no. 2, pages 141 - 148, XP055352338

DOI:   http://dx.doi.org/10.1111/j.1574-6968.2010.02185.x
    - FOY et al., "Behavioral stress impairs long-term potentiation in rodent hippocampus", Behav. Neural Biol., (19870700), vol. 48, no. 1, pages 138 - 149, XP055352341

DOI:   http://dx.doi.org/10.1016/S0163-1047(87)90664-9
    - MATTHIES et al., Learn. Mem., (20000700), vol. 7, pages 227 - 234, XP055352344

DOI:   http://dx.doi.org/10.1101/lm.7.4.227
    - Bartosz Bobula et al, "Imipramine counteracts corticosterone-induced enhancement of glutamatergic transmission and impairment of long-term potentiation in the rat frontal cortex", Pharmacological Reports, vol. 63, no. 6, pages 1404 - 1412, XP055352348

DOI:   http://dx.doi.org/10.1016/S1734-1140(11)70704-6
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.